On the chromatin slide, the possibilities are endless since it alters mRNA function. IMHO many pathological entities will benefit from Anavex. Many more diseases will come on Anavex's way when it proves its efficacy. One thing that striked me is the possibility of improving Parkinson's itself not only Parkinson's dementia. This means that the biochemical improvement will affect many other medical entities. I let my imagination fly.
News 
Market Data 
Discover 
